From Breakthroughs Blog: Malaria

 
PATH/Gabe Bienczycki
Research Roundup: AI advancing drug development, malaria vaccine tested in large clinical trial, and first-in-human universal flu vaccine trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: Tiny guillotine decapitates mosquitoes to fight malaria, new antibody approach to tackling Ebola, and faster and cheaper test to detect Zika

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: CEPI invests in vaccine printer tech, new bednet strategy to fight malaria, and Themis' chikungunya vaccine nabs FDA Fast Track

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Algy Amad
Research Roundup: Pregnant women in DRC to be given Ebola vaccine, releases of genetically modified mosquitoes in high-security lab, and CRISPR may help against viruses for which no vaccine exists

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: DNA from single mosquito sequenced, Pandemic Response Box to boost research, and experimental Ebola treatment proves safe in adults

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Jennifer Fox
As America leads, other nations step up to fund R&D to combat neglected disease threats

The US government has long played an indispensable role in driving global health progress as the world’s leading funder of research and development (R&D) for new vaccines, treatments, and other tools to fight neglected diseases.

Read More
PATH/Mike Wang
Research Roundup: Single-dose drug for recurrent malaria, long-acting contraceptive self-administered via microneedles, and fast diagnosis of viruses

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Satvir Malhotra
Research Roundup: Single-dose Ebola drug, mosquito birth control, and new TB treatment

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Daniel San Martin
Research Roundup: Study maps malaria parasite, global TB research funding hits all-time high, and taking the virus out of a mosquito's bite

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
As the global fight against malaria stalls, malaria vaccine development could be primed for breakout

While the global fight against malaria stalls, we are closer than ever to a world where malaria vaccines join the battle arsenal.

PATH
Read More
PATH/Satvir Malhotra
Research Roundup: Effective experimental Ebola treatments, once-monthly injection to suppress HIV, and malaria-detecting dogs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Research Roundup: Suppository drug cuts child malaria deaths, J&J touts latest immune response data for 'mosaic' HIV vaccine program, and game changer TB drug

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Flickr/macwagen
Play: TRICK or TREATment?

To enjoy a bit of fun and mischief this Halloween, we’ve created a new game, TRICK or TREATment, to test our readers’ knowledge of global health technologies.

Read More
PATH/Dan Chang
Research Roundup: Tech to stop a pandemic, DNA vaccine against Ebola, and a unique way to attack malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Wendy Stone
Research Roundup: Rotavirus vaccine receives WHO prequalification, mosquito repellent paint, and new health security partnership

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: Pledges from the UN High-Level Meeting on TB, TB vaccine trial success, and gene editing mosquitoes

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Wendy Stone
Research Roundup: US launches biodefense strategy, TB remains world's top infectious killer, and human trials begin for antimalarial drug

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Research Roundup: Predatory bacteria, genetically engineered mosquitoes, and tracking disease outbreaks from space

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: Funding gaps in health innovation, new regimen for TB treatment, and a malaria drug resistance model

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Wendy Stone
Research Roundup: Long-acting HIV drugs, a universal flu vaccine candidate, and a low-cost device in the fight against malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Research Roundup: Innovations in bednets, contraception, and Zika vaccination trials

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Wanted: Tools to fight murderous mozzies and their deadly diseases

For World Mosquito Day, GHTC is taking a moment to shine a spotlight on the ghastly gang of mosquito-borne diseases and the innovations we need to finish these frightening foes for good.

Read More
PATH/Patrick McKern
Research Roundup: Congo confirms the end of its Ebola outbreak, new treatments for HIV and malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Georgina Goodwin
Research Roundup: An HIV vaccine shows promise, Paraguay conquers malaria, and tackling malaria using veterinary drugs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Neil Palmer/CIAT
Preparing the ground in the Brazilian Amazon for a new antimalarial to reduce relapse

Tackling malaria in the Brazilian Amazon has proved challenging. But furtunetly, a solution could be in sight.

Read More
PATH/Gabe Bienczycki
Research Roundup: R&D to defeat MRSA, West Nile Virus, and malaria-carrying mosquitoes

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: New work in malaria and HIV diagnostics and a widespread immunization campaign in Brazil

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gena Morgan
Research Roundup: Two malaria drugs power to limit transmission and the latest on chikungunya and cholera vaccines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Satvir Malhotra
Research Roundup: Rotavirus vaccine prequalified and breakthroughs in understanding leprosy and a long-acting malaria medicine

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Doune Porter
Research Roundup: A malaria-fighting toothpaste ingredient and new vaccine candidates for schistosomiasis and tuberculosis

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Georgina Goodwin
Research Roundup: Stem cells and TB, the research agenda to end malaria, and a monkey species role in ending AIDS

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Carib Nelson
Research Roundup: Unlocking a malaria mystery, WHO prequalifies new typhoid vaccine, and the power of vitamin C

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Lynn Heinisch
Research Roundup: Improved Ebola & malaria diagnostics and gene therapy to foster HIV immunity

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Celebrating ten years of GHTC & a decade of progress in global health innovation

As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...

Read More
PATH/Mike Wang
Research Roundup: A powerful single-dose Cholera vaccine, breakthrough in understanding the malaria parasite, and a rapid urine test for TB

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: An old-fashioned malaria strategy, a polio funding crisis, and a global pledge to end TB

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Georgina Goodwin
Research Roundup: Discerning between Zika and dengue, hope for a GBS vaccine, and killer mosquitoes as mosquito control

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Umit Kartoglu
Research Roundup: Forest loss and Ebola, antibody-caused dengue complications, and a mosquito-monitoring platform

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: Technology to save mothers, an all-inclusive vaccine, and malaria's relationship with carbohydrates

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: Hope for an old TB vaccine, delivery drones, and malaria diagnostics

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Novartis
Research Roundup: A new anti-malarial, the promise of probiotics, and genetically-engineered TB

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
CDC/ James Gathany
Research Roundup: Mosquito traps and the impact of antibiotics

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Mike Wang
Research Roundup: Malaria research funding uneven and inequitable, Europe's plan to combat AMR, and unverified malaria medicines on the global market

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Claire Suni
Research Roundup: Venom, technology for smart vector control & animals as a human health threat

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: Malaria and bone density, a fatal vaccine error, and a sponsored Chikungunya trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Doune Porter
Research Roundup: CRISPR concerns, using innovation to cure malaria, and MSF's TB trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Rocky Prajapati
Research Roundup: Potential malaria and Ebola vaccines and the polio vaccine shortage

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Eric Becker
Research Roundup: The rise of drug-resistant TB, ecosystems and pandemics, and a UN-made global mosquito tracker

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Claire Suni
Research Roundup: Barriers to TB immunization, malaria's genetic diversity, and IPM's dapivirine ring

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: Breaking down Zika and opportunities, challenges surrounding global immunization

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Opening up malaria drug discovery for good

Scientists are exploring new open innovation and open source approaches to catalyze malaria drug development and move us closer to achieving the goal of ending malaria for good.

Read More
PATH/Aaron Joel Santos
5 ways science is transforming global health and saving lives

Science expands our understanding, makes the impossible possible, and helps us build the future we want for all people. Science drives the work of GHTC, so we wanted to take a step back to reflect on five ways science is transforming global health.

Read More
US Department of Agriculture/Lance Cheung
Research Roundup: Genetic mutations and innovative ways to package food aid

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: Roadkill reveals new drugs, bracelet saves preemies, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Dunia Faulx
A year in review: The top stories in global health innovation that shaped 2016

As the year comes to an end, GHTC is reflecting on the top stories in global health innovation that made news 2016. 

GHTC
Read More
A cornucopia of thanks

In the spirit of the Thanksgiving holiday, GHTC asked our members and staff to share what they are most thankful for in global health.

Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Long-lasting pills, HIV testing, and starving bacteria of iron

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
David Jacobs
Research Roundup: Pharmaceutical waste and superbugs, resistance to insecticides, and vaccines for crises

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
David Jacobs
Research Roundup: Antibiotics, Zika vaccine R&D, and Ebola and malaria co-infection

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Gabe Bienczycki
Research Roundup: Diagnostics for malaria, premature birth, and women’s health

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
US Navy
Senate votes to protect medical research at DoD

Today the US Senate voted to protect critical medical research programs at the Department of Defense (DoD).

GHTC
Read More
PATH/Jan Jacobs
Research Roundup: a rapid diagnostic for Ebola and fighting mosquito-borne diseases with soap and coconuts

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Research Roundup: an Ebola vaccine, stillbirths, and antimicrobial R&D

Gavi, the Vaccine Alliance, signed an advanced purchase commitment, pledging to spend US$5 million on an Ebola vaccine currently under development by pharmaceutical company Merck & Co.

GHTC
Read More
Obama highlights global health and innovation in State of the Union

GHTC has long championed US leadership in global health and innovation, and we were encouraged to see President Barack Obama highlight these themes in his State of the Union address.

GHTC
Read More
Research Roundup: Ebola treatments, drug-resistant gonorrhea, and zoonotic tuberculosis

A recent clinical trial found that convalescent plasma therapy, a treatment in which the blood plasma is taken from survivors of a disease and used to treat current patients, did not prove to be effective against Ebola.

GHTC
Read More
365 review: Top global health innovation news of 2015

As 2015 draws to a close, the Global Health Technologies Coalition is reflecting on the past year in global health innovation.

GHTC
Read More
Research Roundup: flesh-eating bacteria treatment, Hepatitis C in Egypt, and access to compounds for drug discovery

Global Health Now took an in-depth look at the flesh-eating fungus mycetoma—which enters the body through cuts, and can result in swollen, deformed limbs—in a three-part series on this Untold Global Health Story of 2015.

GHTC
Read More
Research Roundup: the first kid-friendly TB treatment, enlisting smartphones to diagnose malaria, and promising new microbicides

GHTC member TB Alliance announced last week the creation of the first-ever child-friendly tuberculosis (TB) medicines, which are currently undergoing regulatory review by the World Health Organization and should be available in early 2016.

GHTC
Read More
Research Roundup: kid-friendly malaria medicine, Zika fever, priority review vouchers, and more

After four successful Phase 3 clinical trials enrolling more than 3,500 patients in 18 countries, the European Medicines Agency (EMA) has granted Pyramax® Granules, a pediatric malaria medicine, a positive opinion under Article 58—a mechanism through which the EMA reviews and issues a scientific opinion on products that are not intended for use in Europe.

GHTC
Read More
CDC/Prof Woodridge Foster, Prof. Frank H. Collins
Research Roundup: repurposing ivermectin to fight malaria, LED lights against dengue fever, rapid diagnostics to slow antimicrobial resistance, and more

Findings of a study presented at the American Society of Tropical Medicine and Hygiene Annual Meeting last week suggest that ivermectin—a drug long used to treat river blindness and elephantiasis—can combat malaria when used in mass drug administration programs.

GHTC
Read More
CDC/National Institute of Allergy and Infectious Diseases
Research Roundup: an aerosol TB vaccine, a new coating for HIV/AIDS drugs, drug-resistant malaria, and more

Researchers at Tulane University successfully tested an experimental aerosol tuberculosis (TB) vaccine in monkeys, demonstrating that the candidate was more effective in protecting against infection than BCG—the only TB vaccine on the market.

GHTC
Read More
Why we need research to detect, prevent, and ultimately, eliminate parasitic diseases

In this guest post, Dr. Monica Parise—deputy director for program and science—and Dr. Larry Slutsker—director of the Division of Parasitic Disease and Malaria—at the US Centers for Disease Control and Prevention (CDC) Center for Global Health—discuss the role of research in advancing efforts to detect, prevent, and eliminate parasitic diseases.

Read More
Research Roundup: genetic protection against malaria, the vaccine pipeline, and counterfeit drugs and the FDA

A new study conducted by the Malaria Genomic Epidemiology Network (MalariaGEN)—a community of researchers across malaria-endemic regions—reveals a formerly unknown genetic variations that make people less susceptible to malaria.

GHTC
Read More
Research Roundup: combatting malaria with forensics, detecting counterfeit drugs out of a suitcase, and preventing the flu without a vaccine

Luminol has long been used to detect blood at crime scenes, as it glows bright blue when it comes into contact with the blood protein hemoglobin, however, new research suggests that it could be repurposed to fight malaria in humans.

GHTC
Read More
PATH/Gabe Bienczycki
How to accelerate innovation to solve the world's most urgent health issues

In this post, Amie Batson, MBA—chief strategy officer at GHTC member PATH—discusses a new PATH-led initiative to identify and showcase lifesaving innovations with the promise to transform global health by 2030 and offers insights into what it will take to accelerate the impact of innovation. This post originally appeared in the Innovation Countdown 2030 Report: Reimagining Global Health.

PATH
Read More
Passing the ball: DNDi transfers malaria therapies to MMV

The Drugs for Neglected Disease initiative (DNDi) and the Medicines for Malaria Venture (MMV)—nonprofit product development partnerships (PDPs) and members of the Global Health Technologies Coalition—have teamed up to ensure two treatments for malaria continue to reach the patients who need them most.

GHTC
Read More
PATH/Christopher Nelson
Research Roundup: a promising antimalarial and leishmaniasis vaccine, diagnostics for tuberculosis, and more

The Medicines for Malaria Venture (MMV)—a member of the GHTC—and the University of Dundee’s Drug Discovery Unit have developed an antimalarial compound that could treat drug-resistant cases of malaria with a single dose.

GHTC
Read More
World Health Assembly roundup: News on global health research and innovation

The 68th World Health Assembly (WHA) in Geneva wrapped up last week after addressing several items that will shape the next few years of global health innovation.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: resistance to antimalarials in Africa, R&D for bioterrorist attacks, and more

Scientists at the London School of Hygiene and Tropical Medicine have identified a mutation in Plasmodium falciparum—the parasite responsible for the majority of fatal cases of malaria—that makes the parasite more resistant to quinine and artemisinin, the leading antimalarials worldwide.

GHTC
Read More
Photo courtesy of the David and Lucile Packard Foundation.
Could climate change lead to chikungunya? Examining the link between climate change and health

Polar bears and penguins aren’t the only species threatened by climate change.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: publication of clinical trial results, the establishment of an African CDC, and more

The World Health Organization (WHO) released a statement last week calling for the publication of all data from clinical trials for drugs, vaccines, and medical devices.

GHTC
Read More
CDC
Research Roundup: clinical trials for experimental Ebola vaccines, genetic traits that affect malaria risk, and progress toward a hookworm vaccine

The National Institute of Allergy and Infectious Diseases (NIAID) announced last week that two experimental Ebola vaccines appear to be safe for widespread use, based on early results of clinical trials in Liberia.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: discoveries in malaria research, remaining barriers to the development of an Ebola vaccine, and a diagnostic for maternal survival

Scientists at Karolinska Institutet in Sweden have identified the protein that explains why people with blood type O are protected from coma and death resulting from severe cases of malaria.

GHTC
Read More
PATH/Lesley Reed
Research Roundup: Leadership shifts at USAID, new discoveries in tuberculosis research, an emerging model for nonprofit pharmaceutical companies, and more

The US Agency for International Development (USAID) announced last week that Ariel Pabos-Mendez, the assistant administrator for Global Health, will serve as the coordinator for Child and Maternal Survival.

GHTC
Read More
PATH/Heng Chivoan
Research Roundup: A new drug for tuberculosis, contraceptive research and development, drug-resistant malaria, and more

The TB Alliance, a member of the Global Health Technologies Coalition, announced last week that it will be starting Phase 1 clinical trials for a new tuberculosis (TB) drug candidate.

GHTC
Read More
Ten global health advancements I’m thankful for this Thanksgiving

As global health advocates, our work often requires us to focus on unmet needs—such as the number of people worldwide who still die from preventable diseases each year, or the lack of adequate resources and investment to tackle these diseases.

Read More
Why invest in R&D for HIV, TB and malaria? Because it’s good for global health, and good for Europe

In this post, Eoghan Walsh—communications officer at Deutsche Stiftung Weltbevoelkerung (DSW)—writes about the need for Europe to increase financial and political support for efforts aimed at creating new ways to tackle diseases such as HIV/AIDS, tuberculosis (TB) and malaria.

Read More
PATH/Eric Becker
Research Roundup: New malaria drugs, chikungunya vaccines, Africa Leaders Summit, preterm births coalition, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A new era for malaria treatment

In this post, PATH Vice President of Product Development, David Kaslow, writes about the first-ever shipment of semisynthetic artemisinin (ssART)—a new type of malaria treatment that marks a significant milestone in the fight against malaria.

Read More
Anti-malaria drug resistance: a threat to global health security

In this guest post, S. Patrick Kachur, MD, MPH, FACPM—chief of the Malaria Branch in the Division of Parasitic Diseases and Malaria at the Center for Disease Control and Prevention’s (CDC) Center for Global Health—and Larry Slutsker, MD, MPH—director of the Division of Parasitic Diseases and Malaria at CDC’s Center for Global Health—write about the emerging global security threat of anti-malaria drug resistance and CDC’s efforts to prevent, detect, and respond to this growing threat.

Read More
Senate shows strong support for global health R&D in defense appropriations bill and report

Earlier this month, we reported that both the House and Senate Appropriations Committees included language supporting global health research and development (R&D) in their reports concerning funding for the Department of State, foreign operations and related programs.

Read More
House and Senate support global health R&D in appropriations reports

While lawmakers battled it out on the field last week during the annual Congressional Baseball Game (Democrats won for the sixth year in a row!), they found something they could join together on as the House Appropriations Committee easily approved the State and Foreign Operations Subcommittee’s (SFOPS) appropriations bill on Tuesday afternoon.

GHTC
Read More
How R&D is saving #momandbaby and helping children reach their #5thbday

Tomorrow US policymakers and global health advocates will come together to talk progress made on preventing maternal and child deaths.

Read More
PATH/Eric Becker
Research Roundup: New drugs against diarrhea, the End Neglected Tropical Diseases Act, genetically-modified mosquitoes, and mines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
EDCTP2: What it means for European support for global health R&D

In this guest post, Renate Baehr—executive director of Deutsche Stiftung Weltbevoelkerung—writes about the next rendition of the European & Developing Countries Clinical Trials Partnership (EDCTP) and how its expansion will impact more lives in low- and middle-income countries.

Read More
Path/Mike Wang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Big news that could help fight a tiny foe

Most of us know what it’s like to be bitten by a mosquito.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
What we’re looking forward to in 2014

As 2014 gets into full swing, the GHTC is looking ahead to many exciting developments on both the global health research and development (R&D) and policy landscapes:

GHTC
Read More
PATH/Will Boase
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Three key research developments you might have missed from the ASTMH Annual Meeting

In this guest post, Jaclyn Schiff—American Society of Tropical Medicine and Hygiene (ASTMH) Director of Communications—highlights news in global health research presented during the recent ASTMH Annual Meeting.

Read More
New fact sheet outlines the global health R&D pipeline and why US support is so important

In the past, the United States has contributed to important breakthroughs in global health—from the eradication of smallpox to a 74 percent drop in measles deaths worldwide.

GHTC
Read More
PATH/Doune Porter
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More